Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
BWBrainsWay Ltd. logo

BrainsWay Ltd. (BWAY)

NASDAQ Global Market · Currency in USD
$11.25 ▼ -0.19 (-1.66%)
At close: Oct 23, 4:00 PM ET. Market closed.
$11.25 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$11.44
Open
$11.55
Day's Range
$11.09 – $11.55
52 Week Range
$7.14 – $17.40
Volume
52,458
Avg. Volume
112,729
Market Cap
$441.26M
Beta (5Y Monthly)
0.15
PE Ratio (TTM)
46.01
EPS (TTM)
$0.47
Earnings Date
Nov 10, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$19.50

Profile: BrainsWay Ltd.

Sector
Healthcare
Industry
Medical - Specialties
Full-time employees
129
CEO
Hadar Levy

BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease.

Earnings

Next report: Tue, Nov 10, 2026
EPS estimate $0.12 · Revenue est. $17.81M
DateEst.Actual
Aug 12, 2026$0.10$0.14Beat
May 13, 2026$0.05$0.12Beat
Mar 11, 2026$0.06$0.14Beat
Nov 11, 2025$0.05$0.04Miss
Aug 13, 2025$0.04$0.05Beat
May 13, 2025$0.01$0.02Beat

Analyst view

Consensus price target
$19.50 ▲ +73.3%
Range $19.00 – $20.00
Rating: Buy
Buy 88% · Hold 13% · Sell 0%

Get free alerts on BWAY and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.